Allogeneic transplantation of hematopoietic cells is an effective treatment of leukemia, even
in advanced stages. Allogeneic lymphocytes produce a strong graft-versus-leukemia (GVL) …

There is a strong graft-versus-leukemia (GVL) effect of allogeneic stem cell transplantation
(SCT) due to elimination of tumor cells by alloimmune effector lymphocytes. When leukemia …

Given the limited treatment options for relapsed lymphoma post–allogeneic hematopoietic
cell transplantation (post–allo-HCT) and the success of programmed death 1 (PD-1) …

Acute myeloid leukemia (AML) relapse after allogeneic hematopoietic cell transplantation
(alloHCT) remains a major therapeutic challenge. We studied outcomes of 1788 AML …

This study evaluated azacitidine as treatment of minimal residual disease (MRD) determined
by a sensitive donor chimerism analysis of CD34+ blood cells to pre-empt relapse in …

Purpose To evaluate the role of donor lymphocyte infusion (DLI) in the treatment of relapsed
acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation …

Because information on management and outcome of AML relapse after allogeneic
hematopoietic stem cell transplantation (HSCT) with reduced intensity conditioning (RIC) is …

Donor lymphocyte infusion (DLI) into patients with a relapse of their leukemia or multiple
myeloma after allogeneic stem cell transplantation (alloSCT) has been shown to be a …

Natural killer (NK) cells are cytotoxic innate lymphoid cells that protect the host from infection
and mediate anti-tumor responses. Classically considered part of the innate immune system …

Since allogeneic stem cell transplantation (SCT) represents an intensive curative treatment
for high-risk malignancies, its failure to prevent relapse leaves few options for successful …